Guest guest Posted January 8, 2010 Report Share Posted January 8, 2010 http://www.gastrojournal.org/article/PIIS0016508509020356/abstract?rss=yes GASTROENTEROLOGY Volume 138, Issue 1, Pages 6-12.e2 (January 2010) HCV Research 20 Years After Discovery: A Summary of the 16th International Symposium on Hepatitis C Virus and Related Viruses Jean–Michel Pawlotsky‡, ce Cocquerel§, Durantel∥¶#, Dimitri Lavillette‡‡§§, Hervé Lerat‡, Eve–Isabelle Pécheur∥∥, J. Polyak¶¶, Norbert Tautz##, Thimme published online 19 November 2009. The 16th International Symposium on Hepatitis C Virus and Related Viruses took place in Nice, France, on October 3–7, 2009, almost exactly 20 years after Houghton and colleagues reported discovery of the hepatitis C virus (HCV). At that time, the disease was known as “non-A, non-B hepatitis,†and its prevalence was underestimated. Now, approximately 170 million individuals worldwide are infected; chronic HCV infection is the leading indication for liver transplantation and one of the principal causes of primary liver cancer in industrialized countries. Abbreviations used in this paper: apo, apolipoprotein, CTLA-4, cytotoxic T-lymphocyte antigen 4, ER, endoplasmic reticulum, GADD45β, growth arrest and DNA damage-inducible 45β, GRE, GU-rich element, HVR1, hypervariable region 1, IFN, interferon, IL, interleukin, IRF, interferon-regulatory factor, ISG, interferon-stimulated gene, LNA, locked nucleic acid, LVP, lipo-viro-particle, PD-1, programmed death 1, PKR, protein kinase RNA activated, RdRp, RNA-dependent RNA polymerase, RIG-I, retinoic acid inducible gene I, siRNA, silencing RNA, TGF, transforming growth factor, TLR, toll-like receptor National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Henri Mondor Hospital, University of Paris 12, Créteil, France ‡ INSERM Unité 955, Créteil, France § Institut de Biologie de Lille, CNRS-UMR8161, Université Lille-Nord de France, Institut Pasteur de Lille, Lille, France ∥ INSERM Unité 871, Molecular Physiopathology and New Treatment of Viral Hepatitis, Lyon, France ¶ Université de Lyon, UCB-Lyon1, IFR62, Lyon, France # Hospices Civils de Lyon, Lyon, France Université de Lyon, UCB-Lyon1, IFR128, Lyon, France ‡‡ INSERM Unité 758, Lyon, France §§ Ecole Normale Supérieure de Lyon, Lyon, France ∥∥ Institut de Biologie et Chimie des Protéines, UMR CNRS 5086, Université Lyon 1, IFR128 Lyon Biosciences Gerland, Lyon, France ¶¶ Division of Virology, Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington ## Institute of Virology and Cell Biology, University of Lübeck, Lübeck, Germany Department of Medicine II, University of Freiburg, Freiburg, Germany Reprint requests Address requests for reprints to: Jean-Michel Pawlotsky, MD, PhD, Department of Virology, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France. fax: (33) 1-4981-4831 Conflicts of interest The authors disclose no conflicts. PII: S0016-5085(09)02035-6 doi:10.1053/j.gastro.2009.11.018 © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.